NO129743B - - Google Patents
Download PDFInfo
- Publication number
- NO129743B NO129743B NO01536/70A NO153670A NO129743B NO 129743 B NO129743 B NO 129743B NO 01536/70 A NO01536/70 A NO 01536/70A NO 153670 A NO153670 A NO 153670A NO 129743 B NO129743 B NO 129743B
- Authority
- NO
- Norway
- Prior art keywords
- compound
- formula
- nitrofurfural
- filtered
- sulfanilylamido
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 17
- SXINBFXPADXIEY-UHFFFAOYSA-N 5-Nitrofurfural Chemical compound [O-][N+](=O)C1=CC=C(C=O)O1 SXINBFXPADXIEY-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- IBWYHNOFSKJKKY-UHFFFAOYSA-N 3-chloropyridazine Chemical group ClC1=CC=CN=N1 IBWYHNOFSKJKKY-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229940124530 sulfonamide Drugs 0.000 description 4
- 150000003456 sulfonamides Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- -1 2-(p-benzylidene-amino-benzenesulfonamido)-6-methoxy-pyridazine Chemical compound 0.000 description 1
- 241001622982 Bombus soroeensis proteus Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000002192 coccidiostatic effect Effects 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
- C07D241/22—Benzenesulfonamido pyrazines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI000882 | 1969-04-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO129743B true NO129743B (enExample) | 1974-05-20 |
Family
ID=10994361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO01536/70A NO129743B (enExample) | 1969-04-23 | 1970-04-22 |
Country Status (11)
| Country | Link |
|---|---|
| AT (1) | AT295543B (enExample) |
| CA (1) | CA969543A (enExample) |
| CH (1) | CH530987A (enExample) |
| CS (1) | CS171332B1 (enExample) |
| DE (1) | DE2017813A1 (enExample) |
| ES (1) | ES378923A1 (enExample) |
| FR (1) | FR2042363B1 (enExample) |
| GB (1) | GB1305756A (enExample) |
| IL (1) | IL34362A0 (enExample) |
| NO (1) | NO129743B (enExample) |
| PL (1) | PL82623B1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB858847A (en) * | 1958-02-03 | 1961-01-18 | American Cyanamid Co | N-acylated sulfa drugs and preparation thereof |
-
1970
- 1970-04-14 DE DE19702017813 patent/DE2017813A1/de active Pending
- 1970-04-16 AT AT345570A patent/AT295543B/de not_active IP Right Cessation
- 1970-04-16 GB GB1824870A patent/GB1305756A/en not_active Expired
- 1970-04-20 IL IL34362A patent/IL34362A0/xx unknown
- 1970-04-21 CS CS2708A patent/CS171332B1/cs unknown
- 1970-04-21 CH CH595170A patent/CH530987A/de not_active IP Right Cessation
- 1970-04-22 ES ES378923A patent/ES378923A1/es not_active Expired
- 1970-04-22 NO NO01536/70A patent/NO129743B/no unknown
- 1970-04-23 CA CA080,926A patent/CA969543A/en not_active Expired
- 1970-04-23 FR FR7014782A patent/FR2042363B1/fr not_active Expired
- 1970-04-23 PL PL1970140203A patent/PL82623B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2042363A1 (enExample) | 1971-02-12 |
| AT295543B (de) | 1972-01-10 |
| GB1305756A (enExample) | 1973-02-07 |
| CH530987A (de) | 1972-11-30 |
| CA969543A (en) | 1975-06-17 |
| ES378923A1 (es) | 1973-04-16 |
| IL34362A0 (en) | 1970-06-17 |
| FR2042363B1 (enExample) | 1974-02-01 |
| DE2017813A1 (de) | 1970-12-10 |
| CS171332B1 (enExample) | 1976-10-29 |
| PL82623B1 (en) | 1975-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2066324C1 (ru) | Кристаллический дигидрат азитромицина и способ его получения | |
| NO334115B1 (no) | Etyl 3-[(2-{[4-(heksyloksykarbonylamino-imino-metyl)-fenylamino]-metyl}-1-metyl-1H-benzimidazol-5-karbonyl)-pyridin-2-yl-amino]-propionat-metansulfonat i krystallinsk form, fremgangsmåte for fremstilling samt farmasøytisk preparat inneholdende samme | |
| KR20120139763A (ko) | 랄테그라비어 염 및 이의 결정형 | |
| EP0058614B1 (en) | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8 naphtyridine-3-carboxylic acid. sesquihydrate, processes for the preparation thereof and use thereof as antibacterial agents | |
| US4057548A (en) | Process for preparing methotrexate or an N-substituted derivative thereof and/or a di (lower) alkyl ester thereof and precursor therefor | |
| US4067867A (en) | Process for preparing pyrazine precursor of methotrexate or an N-substituted derivative thereof and/or a di(lower)alkyl ester thereof | |
| CN109928963B (zh) | 一种抗菌药物三碳链甲基哌啶尿石素b及其盐酸盐的合成方法和应用 | |
| JPS60126284A (ja) | ピリドンカルボン酸誘導体およびその塩 | |
| NO129743B (enExample) | ||
| SU1491339A3 (ru) | Способ получени кристаллической формы моноэтаноламиновой соли N-(2-пиридил)-2-метил-4-окси-2Н-1,2-бензотиазин-3-карбоксамида 1,1-диоксида-полиморфа @ | |
| IE902115L (en) | Crystalline cephem acid addition salts | |
| CN111560029B (zh) | 一种三唑并苯并噻唑衍生物的制备方法 | |
| Bristow et al. | Meso-ionic compounds derived from pyridino (1′: 2′-1: 2) glyoxaline | |
| KR101876750B1 (ko) | 신규한 2-아민 치환 1,4-나프토퀴논 화합물 및 이를 포함하는 암의 예방 또는 치료용 약제학적 조성물 | |
| EA029363B1 (ru) | Фармацевтические составы, содержащие 3-(4-циннамил-1-пиперазинил)аминопроизводные 3-формил рифамицина sv и 3-формил рифамицина s, и способ их получения | |
| KR100364941B1 (ko) | 1-[5-메탄설폰아미도인돌릴-2-카보닐]-4-[3-(1-메틸에틸아미노)-2-피리디닐]피페라진의신규한결정형태 | |
| CA2101571A1 (en) | Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof | |
| US2545962A (en) | Homosulfanilamide salt of aspergillic acid and method of preparing same | |
| SU545259A3 (ru) | Способ получени -замещенных циклосериновых соединений или их солей | |
| US3804836A (en) | N-phenyl-n'-dialkylphosphinylalkyl-piperazines | |
| US3288793A (en) | 2-tetrahydrofurfuryl-, 2-aliphatic-, and 2-aliphatic ether-sulfonamido-5-alkoxy-pyrimidines | |
| US20250011348A1 (en) | Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof | |
| SU858565A3 (ru) | Способ получени производных 1,3-пергидротиазина | |
| Poliakoff et al. | Synthetic trypanocides. 3. Structure-activity relations | |
| US4218465A (en) | Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions |